Tag: Aleva Neurotherapeutics
Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system
Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...
FDA grants Aleva Neurotherapeutics approval for IDE study with directSTIM system
Aleva Neurotherapeutics has received a letter of approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) study assessing...
Aleva Neurotherapeutics receives CE mark for its directSTIM directional Deep Brain...
Aleva Neurotherapeutics has announced that it has been awarded the CE mark for its flagship product, the directSTIM Deep Brain Stimulation System. The system...
Aleva Neurotherapeutics raises US$13 million in latest financing round
Aleva Neurotherapeutics has raised US$13 million in a Series D financing round. The round was led by Forrestal Capital, a fund with specific experience...
